Economic Evaluation of Lumos Diagnostics’ FebriDx® Point-of-Care Test Highlights $2.5 Billion in Potential U.S. Healthcare Cost Savings Annually
Journal of Health Economics and Outcomes Research Publishes Cost Impact of the Novel, Rapid Point-of-Care…